The Role of the IL-4 Signaling Pathway in Traumatic Nerve Injuries.
John M Daines, Lauren Schellhardt, Matthew D Wood
PMID 33754913WHAT IT FOUND
IL-4 signaling helps nerves heal in mice, but no human trials exist.
Therapists should not expect IL-4 to improve recovery. This mechanism explains why nerve repair often fails and why surgery outcomes remain poor.
Key findings
01Despite nerve repair surgery, only 52% of median and 43% of ulnar nerve reconstructions achieve satisfactory motor and sensory recovery.
02IL-4 promotes nerve regeneration in rodent models by shifting immune cells to a healing phenotype and aiding Schwann cell function.
03Exogenous IL-4 treatment risks fibrosis and chronic inflammation if not carefully targeted, limiting its current clinical use.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a review of animal and in vitro studies, not human clinical trials. The authors state that more research is needed to translate these findings to humans. There is no data on the safety or efficacy of IL-4 therapy in people. The review notes that chronic IL-4 signaling can lead to harmful fibrosis, meaning the therapy is not straightforward.
Declared interests
The authors have no competing interests to declare.
The easy way to misread this
Do not interpret this review as evidence that IL-4 therapy is available or effective for patients. It is a basic science summary of animal models. Clinical application is years away, and current treatments for nerve injury remain surgical and rehabilitative.